Bill > H1222

This bill aims to prohibit health insurers from requiring annual re-authorizations for certain prescription medications used to treat chronic diseases. Specifically, the legislation would prevent insurers operating under several Massachusetts healthcare law chapters from mandating yearly reviews and approvals for prescription drugs prescribed by medical professionals (physicians, physician's assistants, or nurse practitioners) to manage chronic conditions such as diabetes, heart disease, Alzheimer's disease, cancer, stroke, and respiratory diseases. Re-authorization is a process where patients must periodically get renewed approval from their insurance company to continue receiving a specific medication, which can create additional administrative burden and potential disruptions in medical treatment. By eliminating the annual re-authorization requirement for these chronic disease medications, the bill seeks to streamline healthcare access and reduce potential barriers to consistent medical treatment for patients managing long-term health conditions.

Business and Industry, Health and Social Services

https://malegislature.gov/Bills/194/H1222